Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/37618
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLi, Benen_UK
dc.contributor.authorPowell, Dylanen_UK
dc.contributor.authorLee, Regenten_UK
dc.date.accessioned2025-12-02T01:02:18Z-
dc.date.available2025-12-02T01:02:18Z-
dc.date.issued2025-11-18en_UK
dc.identifier.other454en_UK
dc.identifier.urihttp://hdl.handle.net/1893/37618-
dc.description.abstractArtificial intelligence (AI) is already having a significant impact on healthcare. For example, AI-guided imaging can improve the diagnosis/treatment of vascular diseases, which affect over 200 million people globally. Recently, Chiu and colleagues (2024) developed an AI algorithm that supports nurses with no ultrasound training in diagnosing abdominal aortic aneurysms (AAA) with similar accuracy as ultrasound-trained physicians. This technology can therefore improve AAA screening; however, achieving clinical impact with new AI technologies requires careful consideration of commercialization strategies, including funding, compliance with safety and regulatory frameworks, health technology assessment, regulatory approval, reimbursement, and clinical guideline integration.en_UK
dc.language.isoenen_UK
dc.publisherSpringer Science and Business Media LLCen_UK
dc.relationLi B, Powell D & Lee R (2025) Commercialization of medical artificial intelligence technologies: challenges and opportunities. <i>npj Digital Medicine</i>, 8, Art. No.: 454. https://doi.org/10.1038/s41746-025-01867-wen_UK
dc.rightsThis article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.en_UK
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_UK
dc.titleCommercialization of medical artificial intelligence technologies: challenges and opportunitiesen_UK
dc.typeJournal Articleen_UK
dc.identifier.doi10.1038/s41746-025-01867-wen_UK
dc.identifier.pmid40676253en_UK
dc.citation.jtitlenpj Digital Medicineen_UK
dc.citation.issn2398-6352en_UK
dc.citation.issn2398-6352en_UK
dc.citation.volume8en_UK
dc.citation.publicationstatusPublisheden_UK
dc.citation.peerreviewedRefereeden_UK
dc.type.statusVoR - Version of Recorden_UK
dc.contributor.funderUniversity of Stirlingen_UK
dc.contributor.funderEuropean Commission (Horizon Europe)en_UK
dc.contributor.funderUK Research and Innovationen_UK
dc.author.emaildylan.powell@stir.ac.uken_UK
dc.citation.date18/07/2025en_UK
dc.contributor.affiliationUniversity of Torontoen_UK
dc.contributor.affiliationHealth Sciences Stirlingen_UK
dc.contributor.affiliationUniversity of Oxforden_UK
dc.identifier.isiWOS:001531508100001en_UK
dc.identifier.scopusid105011208802en_UK
dc.identifier.wtid2212773en_UK
dc.contributor.orcid0000-0003-1233-5468en_UK
dc.date.accepted2025-07-05en_UK
dcterms.dateAccepted2025-07-05en_UK
dc.date.filedepositdate2025-11-28en_UK
rioxxterms.apcnot requireden_UK
rioxxterms.versionVoRen_UK
local.rioxx.authorLi, Ben|en_UK
local.rioxx.authorPowell, Dylan|0000-0003-1233-5468en_UK
local.rioxx.authorLee, Regent|en_UK
local.rioxx.projectProject ID unknown|European Commission (Horizon Europe)|en_UK
local.rioxx.projectProject ID unknown|UK Research and Innovation|http://dx.doi.org/10.13039/100014013en_UK
local.rioxx.projectProject ID unknown|University of Stirling|en_UK
local.rioxx.freetoreaddate2025-11-28en_UK
local.rioxx.licencehttp://creativecommons.org/licenses/by-nc-nd/4.0/|2025-11-28|en_UK
local.rioxx.filenames41746-025-01867-w.pdfen_UK
local.rioxx.filecount1en_UK
local.rioxx.source2398-6352en_UK
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles

Files in This Item:
File Description SizeFormat 
s41746-025-01867-w.pdfFulltext - Published Version1.11 MBAdobe PDFView/Open


This item is protected by original copyright



A file in this item is licensed under a Creative Commons License Creative Commons

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.